| Combining zebrafish and CRISPR/Cas9: toward a more efficient drug discovery pipeline C Cornet, V Di Donato, J Terriente Frontiers in pharmacology 9, 384372, 2018 | 108 | 2018 |
| ZeGlobalTox: an innovative approach to address organ drug toxicity using zebrafish C Cornet, S Calzolari, R Miñana-Prieto, S Dyballa, E Van Doornmalen, ... International journal of molecular sciences 18 (4), 864, 2017 | 91 | 2017 |
| Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy DC Pant, I Dorboz, A Schluter, S Fourcade, N Launay, J Joya, ... The Journal of clinical investigation 129 (3), 1240-1256, 2019 | 69 | 2019 |
| Comparison of zebrafish larvae and hiPSC cardiomyocytes for predicting drug-induced cardiotoxicity in humans S Dyballa, R Minana, M Rubio-Brotons, C Cornet, T Pederzani, ... Toxicological Sciences 171 (2), 283-295, 2019 | 31 | 2019 |
| ZeOncoTest: refining and automating the zebrafish xenograft model for drug discovery in cancer C Cornet, S Dyballa, J Terriente, V Di Giacomo Pharmaceuticals 13 (1), 1, 2019 | 23 | 2019 |
| CRISPR meets zebrafish: accelerating the discovery of new therapeutic targets D Rubbini, C Cornet, J Terriente, V Di Donato SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (6), 552-567, 2020 | 17 | 2020 |
| Mutations in the non-structural protein-coding sequence of protoparvovirus H-1PV enhance the fitness of the virus and show key benefits regarding the transduction efficiency of … H Hashemi, AL Condurat, A Stroh-Dege, N Weiss, C Geiss, J Pilet, ... Viruses 10 (4), 150, 2018 | 5 | 2018 |
| Fishing for innovative alternatives for modeling epilepsy C Cornet | | |
Javier TerrienteZeClinicsVerified email at zeclinics.com
Javier TerrienteZeClinicsVerified email at zeclinics.com